Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays.

Siljee JE, Wortelboer EJ, Koster MP, Imholz S, Rodenburg W, Visser GH, de Vries A, Schielen PC, Pennings JL.

Prenat Diagn. 2013 Dec;33(12):1183-8. doi: 10.1002/pd.4219. Epub 2013 Aug 31.

PMID:
23943085
2.

First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.

Yliniemi A, Nurkkala MM, Kopman S, Korpimaki T, Kouru H, Ryynanen M, Marttala J.

Metabolism. 2015 Apr;64(4):521-6. doi: 10.1016/j.metabol.2014.12.008. Epub 2014 Dec 26.

PMID:
25633269
3.

Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening.

Koster MP, Pennings JL, Imholz S, Rodenburg W, Visser GH, de Vries A, Schielen PC.

Prenat Diagn. 2009 Sep;29(9):857-62. doi: 10.1002/pd.2294.

PMID:
19488973
4.

A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.

Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS.

Ultrasound Obstet Gynecol. 2006 Jan;27(1):13-7.

5.
6.

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.

Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K.

Prenat Diagn. 2009 Aug;29(8):781-9. doi: 10.1002/pd.2287.

PMID:
19418482
7.

First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.

Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH.

Ultrasound Obstet Gynecol. 2009 Jan;33(1):23-33. doi: 10.1002/uog.6280.

8.

Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.

Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH.

Prenat Diagn. 2009 Dec;29(12):1103-8. doi: 10.1002/pd.2375.

PMID:
19777530
9.

Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia.

Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, Karagiannis V, Tarlatzis BC.

Am J Reprod Immunol. 2011 Dec;66(6):468-75. doi: 10.1111/j.1600-0897.2011.01019.x. Epub 2011 May 30.

PMID:
21623995
10.

First-trimester metabolomic detection of late-onset preeclampsia.

Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K.

Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.

PMID:
23159745
11.

Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.

Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH.

J Matern Fetal Neonatal Med. 2013 May;26(8):733-7. doi: 10.3109/14767058.2012.755167. Epub 2013 Jan 10.

PMID:
23205865
12.

Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.

Banzola I, Farina A, Concu M, Sekizawa A, Purwosunu Y, Strada I, Arcelli D, Simonazzi G, Caramelli E, Rizzo N.

Prenat Diagn. 2007 Nov;27(11):1005-10.

PMID:
17654753
13.

The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsia.

Xu QL, Zhu M, Jin Y, Wang N, Xu HX, Quan LM, Wang SS, Li SS.

Peptides. 2014 Dec;62:150-4.

PMID:
25445606
14.

Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening.

Boucoiran I, Suarthana E, Rey E, Delvin E, Fraser WB, Audibert F.

Am J Perinatol. 2013 Sep;30(8):681-8. doi: 10.1055/s-0032-1331025. Epub 2013 Feb 5.

PMID:
23386402
15.

First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia.

Svirsky R, Meiri H, Herzog A, Kivity V, Cuckle H, Maymon R.

J Perinat Med. 2013 Sep 1;41(5):561-6. doi: 10.1515/jpm-2013-0011.

PMID:
23729534
16.

First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.

Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH.

Placenta. 2013 Nov;34(11):1059-65. doi: 10.1016/j.placenta.2013.08.006. Epub 2013 Aug 28.

PMID:
23993394
17.

Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.

Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.

J Matern Fetal Neonatal Med. 2013 May;26(8):763-7. doi: 10.3109/14767058.2012.755168. Epub 2013 Mar 25.

PMID:
23205868
18.

Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.

Huang T, Hoffman B, Meschino W, Kingdom J, Okun N.

Prenat Diagn. 2010 May;30(5):471-7. doi: 10.1002/pd.2505.

PMID:
20440736
19.

Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.

Wald NJ, Morris JK, Ibison J, Wu T, George LM.

Prenat Diagn. 2006 Jun;26(6):559-64.

PMID:
16700087
20.

Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.

Spencer K, Cowans NJ, Nicolaides KH.

Ultrasound Obstet Gynecol. 2008 Oct;32(5):622-6. doi: 10.1002/uog.6212.

Supplemental Content

Support Center